1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for DRMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2022. Start Trial.
Date Value
September 04, 2026 -78.00%
September 03, 2026 -79.15%
September 02, 2026 -77.85%
September 01, 2026 -77.35%
August 31, 2026 -77.53%
August 28, 2026 -74.95%
August 27, 2026 -72.40%
August 26, 2026 -70.73%
August 25, 2026 -70.50%
August 24, 2026 -70.26%
August 21, 2026 -73.36%
August 20, 2026 -74.49%
August 19, 2026 -73.91%
August 18, 2026 -75.84%
August 17, 2026 -75.59%
August 14, 2026 -74.87%
August 13, 2026 -75.64%
August 12, 2026 -77.41%
August 11, 2026 -82.46%
August 10, 2026 -82.65%
August 07, 2026 -82.73%
August 06, 2026 -82.98%
August 05, 2026 -83.26%
August 04, 2026 -84.42%
August 03, 2026 -83.33%
Date Value
July 31, 2026 -81.23%
July 30, 2026 -80.73%
July 29, 2026 -83.29%
July 28, 2026 -82.43%
July 27, 2026 -81.55%
July 24, 2026 -81.12%
July 23, 2026 -82.37%
July 22, 2026 -81.92%
July 21, 2026 -81.58%
July 20, 2026 -80.59%
July 17, 2026 -80.53%
July 16, 2026 -81.74%
July 15, 2026 -82.20%
July 14, 2026 -81.89%
July 13, 2026 -80.99%
July 10, 2026 -81.38%
July 09, 2026 -79.38%
July 08, 2026 -77.78%
July 07, 2026 -79.71%
July 06, 2026 -79.82%
July 02, 2026 -79.91%
July 01, 2026 -78.46%
June 30, 2026 -77.95%
June 29, 2026 -78.49%
June 26, 2026 -77.99%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Anika Therapeutics, Inc. 128.9%
Perspective Therapeutics, Inc. -11.58%
MiMedx Group, Inc. -35.54%
ABVC BioPharma, Inc. -65.03%
Endonovo Therapeutics, Inc. 0.00%